Log In
BCIQ
Print this Print this
 

Karbinal, Karbinal ER carbinoxamine maleate (Extended Release Carbinoxamine Oral Suspension)

  Manage Alerts
Collapse Summary General Information
Company Tris Pharma Inc.
DescriptionOral antihistamine is formulated with Tris' OralXR+ technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.0M

0

$20.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/09/2013

$20.0M

0

$20.0M

Get a free BioCentury trial today